Your browser doesn't support javascript.
loading
A phase II study of FOLFIRINOX with primary prophylactic pegfilgrastim for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer.
Sasaki, Mitsuhito; Ueno, Hideki; Mitsunaga, Shuichi; Ohba, Akihiro; Hosoi, Hiroko; Kobayashi, Satoshi; Ueno, Makoto; Terazawa, Tetsuji; Goto, Masahiro; Inoue, Dai; Namiki, Shin; Sakamoto, Yasunari; Kondo, Shunsuke; Morizane, Chigusa; Ikeda, Masafumi; Okusaka, Takuji.
Afiliación
  • Sasaki M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. mitsasak@east.ncc.go.jp.
  • Ueno H; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan. mitsasak@east.ncc.go.jp.
  • Mitsunaga S; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Ohba A; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
  • Hosoi H; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Kobayashi S; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Ueno M; Division of Hepatobiliary and Pancreatic Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
  • Terazawa T; Division of Hepatobiliary and Pancreatic Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
  • Goto M; Cancer Chemotherapy Center, Osaka Medical College Hospital, Takatsuki, Osaka, Japan.
  • Inoue D; Cancer Chemotherapy Center, Osaka Medical College Hospital, Takatsuki, Osaka, Japan.
  • Namiki S; Department of Gastroenterology and Hepatology, Tokyo Metropolitan Tama Medical Center, Fuchu, Tokyo, Japan.
  • Sakamoto Y; Department of Gastroenterology and Hepatology, Tokyo Metropolitan Tama Medical Center, Fuchu, Tokyo, Japan.
  • Kondo S; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Morizane C; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Ikeda M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Okusaka T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
Int J Clin Oncol ; 26(11): 2065-2072, 2021 Nov.
Article en En | MEDLINE | ID: mdl-34368921
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Japón